Drugs / tumor derived microparticles
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02657460 | Jan 2016 → Dec 2019 | pleural neoplasm | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tumor derived microparticles | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02657460 ↗ |
| Known as | methotrexate-autologous tumor derived microparticles | “So the investigators attempt to explore the anticancer effect and related immune regulation mechanism of methotrexate-autologous tumor derived microparticles (MTX-ATMPs) in MPE...” NCT02657460 ↗ |